Audio Interview: A New SARS-CoV-2 Vaccine and a New Look at Treatment

N Engl J Med. 2021 Mar 4;384(9):e46. doi: 10.1056/NEJMe2103680.
No abstract available

Publication types

  • Editorial
  • Interview

MeSH terms

  • Ad26COVS1
  • Adenoviridae
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • COVID-19 / prevention & control*
  • COVID-19 Drug Treatment*
  • COVID-19 Vaccines* / administration & dosage
  • COVID-19 Vaccines* / immunology
  • Genetic Variation
  • Genetic Vectors
  • Humans
  • Immunologic Factors / therapeutic use*
  • Interleukin-6 / immunology
  • Receptors, Interleukin-6 / antagonists & inhibitors*
  • SARS-CoV-2 / genetics*
  • Treatment Outcome
  • Vaccine Potency

Substances

  • Ad26COVS1
  • Antibodies, Monoclonal, Humanized
  • COVID-19 Vaccines
  • Immunologic Factors
  • Interleukin-6
  • Receptors, Interleukin-6
  • tocilizumab